Neoadjuvant TherapyChemotherapy, AdjuvantEsophagectomyChemoradiotherapy, AdjuvantAntineoplastic Combined Chemotherapy ProtocolsBreast NeoplasmsRadiotherapy, AdjuvantRectal NeoplasmsTreatment OutcomeCombined Modality TherapyNeoplasm StagingEsophageal NeoplasmsFluorouracilTaxoidsAdenocarcinomaEpirubicinDisease-Free SurvivalChemoradiotherapyPrognosisDoxorubicinCisplatinAntineoplastic AgentsReceptor, erbB-2Neoplasm Recurrence, LocalSurvival RateDeoxycytidineSarcomaRetrospective StudiesCyclophosphamideSurvival AnalysisPancreatic NeoplasmsAntibodies, Monoclonal, HumanizedPaclitaxelNeoplasm, ResidualAntineoplastic Agents, HormonalLymphatic MetastasisAnthracyclinesPositron-Emission TomographyPancreatectomyPancreaticoduodenectomyFluorodeoxyglucose F18Receptors, EstrogenNomogramsTumor Markers, BiologicalCarcinoma, Squamous CellCystectomyOrganoplatinum CompoundsKaplan-Meier EstimatePredictive Value of TestsProspective StudiesPreoperative CareFollow-Up StudiesEsophagogastric JunctionMastectomy, SegmentalTomography, X-Ray ComputedTumor BurdenBiomarkers, PharmacologicalProstatectomyRadiopharmaceuticalsLeucovorinCarcinoma, Ductal, BreastMuscle NeoplasmsReceptors, ProgesteroneOsteosarcomaCarcinoma, Pancreatic DuctalCarcinomaCarcinoma, LobularDrug Administration ScheduleSoft Tissue NeoplasmsBridged CompoundsVinblastineMultivariate AnalysisNitrilesKi-67 AntigenTime FactorsImmunohistochemistryMastectomyAndrogen AntagonistsNeoplasm MetastasisUrinary Bladder NeoplasmsMultimodal ImagingMethotrexateLymph Node ExcisionFlutamideTriazolesAntibodies, MonoclonalBone NeoplasmsNeoplasm GradingCarboplatinAxillaNeoplasm InvasivenessLung NeoplasmsIfosfamideGoserelinRadiotherapy DosageRemission InductionCarcinoma, Transitional Cell